1-11 of 11
Andrew Hantel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer

Lauren E. Merz, Yating Wang, Elad Sharon, Thomas P Walsh, Gregory Abel, Andrew Hantel
Journal: Blood
Blood (2024) 144 (Supplement 1): 5073.
https://doi.org/10.1182/blood-2024-201828
Published: 2024
Journal Articles

Impact of Social Determinants of Health on Overall Survival in Patients with AML By European Leukemianet Risk Group

Shai O. Shimony, Yating Wang, Angel Cronin, Thomas P Walsh, Anne Charles, Natalie Slopen, Maximilian Stahl, Rebecca P. Bystrom, Marlise R. Luskin, Gregory Abel, Daniel J. DeAngelo, Richard M Stone, R. Coleman Lindsley, Andrew Hantel
Journal: Blood
Blood (2024) 144 (Supplement 1): 5171.
https://doi.org/10.1182/blood-2024-203644
Published: 2024
Journal Articles

A National Survey of Oncologists' Perspectives on the Ethical Implications of Artificial Intelligence in Cancer Care

Andrew Hantel, Jonathan M. Marron, Kenneth Kehl, Richard Sharp, Thomas P Walsh, Eliezer Van Allen, Gregory A Abel
Journal: Blood
Blood (2023) 142 (Supplement 1): 2347.
https://doi.org/10.1182/blood-2023-175030
Published: 2023
Journal Articles

Characterization of Comparative Clinical Outcomes and Molecular Features of Black Patients with Acute Promyelocytic Leukemia (APL) Reveals Similar Survival and Distinct Genomic Profiles

Alma Habib, Isaiah Boateng, Deedra Nicolet, Krzysztof Mrózek, James L Fisher, Allyson Waller, Andrew Stiff, Jill Buss, Andrea Laganson, Sienna Martinez Corzine, Ethan Hamp, Yazan Abu-Shihab, Bayard L Powell, Geoffrey L Uy, Wendy Stock, Richard M Stone, Jonathan E Kolitz, Eunice S. Wang, Andrew J Carroll, Jeffrey W Tyner, Andrew Hantel, Electra D Paskett, John C. Byrd, Elaine R Mardis, Jesse J Plascak, Ann-Kathrin Eisfeld
Journal: Blood
Blood (2023) 142 (Supplement 1): 389.
https://doi.org/10.1182/blood-2023-182376
Published: 2023
Journal Articles

Alignment of Later Phase Clinical Trial Eligibility Criteria with Drug Safety in Acute Leukemia: Minimizing Unnecessary Patient Risk and Exclusion

Elizabeth Warner, Thomas P Walsh, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A Abel, Andrew Hantel
Journal: Blood
Blood (2023) 142 (Supplement 1): 263.
https://doi.org/10.1182/blood-2023-174880
Published: 2023
Journal Articles

Development of a Real-Time Dashboard Characterizing Acute Leukemia Clinical Trial Enrollment Diversity at the Practice, Investigator, and Individual Clinician Level

Andrew Hantel, Kelsey Y Li, Saima Awan, Thomas P Walsh, Emerald D Littlejohn, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A Abel
Journal: Blood
Blood (2023) 142 (Supplement 1): 132.
https://doi.org/10.1182/blood-2023-174899
Published: 2023
Journal Articles

Access and Treatment Equity across the Comprehensive Cancer Center Catchment Area: Targets for Disparities Remediation in Acute Leukemia Research Participation

Andrew Hantel, Marlise R. Luskin, Timothy R. Rebbeck, Andrew M. Brunner, Dillon D. Clancy, Richard M. Stone, Daniel J DeAngelo, Christopher S. Lathan, Gregory A. Abel
Journal: Blood
Blood (2022) 140 (Supplement 1): 926–927.
https://doi.org/10.1182/blood-2022-166568
Published: 2022
Journal Articles

Stakeholder Perceptions of Barriers to Diverse Acute Myeloid Leukemia Clinical Trial Enrollment at Comprehensive Cancer Centers

Andrew Hantel, Jane Roberts, Anna Revette, Christopher S. Lathan, Gregory A. Abel
Journal: Blood
Blood (2021) 138 (Supplement 1): 3014.
https://doi.org/10.1182/blood-2021-147830
Published: 2021
Journal Articles

Race-Ethnic Enrollment Disparities over 15 Years of Alliance/CALGB Acute Myeloid Leukemia Clinical Trials, Biobanks, and Correlative Science Protocols

Andrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Wendy Stock, Sawyer Jacobson, Sumithra J Mandrekar, Richard M. Stone, Daniel J. DeAngelo, John C. Byrd, Gregory A. Abel
Journal: Blood
Blood (2021) 138 (Supplement 1): 111.
https://doi.org/10.1182/blood-2021-146607
Published: 2021
Journal Articles

The Impact of Different Ethical Allocation Strategies on Survival during Vincristine Shortages

Andrew Hantel, MD, Michael McManus, MD MPH, Gregory A. Abel, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 59–60.
https://doi.org/10.1182/blood-2020-136643
Published: 2020
Journal Articles

Efficacy of Single-Agent Decitabine in Relapsed and Primary Refractory (rel/ref) Acute Myeloid Leukemia (AML)

Andrew Hantel, MD, Niloufer Khan, MD, Richard A. Larson, MD, Lucy A. Godley, MD PhD, Michael J. Thirman, MD, Andrew Artz, MD MS, Olatoyosi Odenike, MD, Hongtao Liu, MDPhD, Jane E. Churpek, MD, Darren King, MD, Elizabeth Rich, MD, Kwang Jin Choi, MD, Randall W. Knoebel, PharmD, BCOP, Wendy Stock, MD
Journal: Blood
Blood (2015) 126 (23): 2518.
https://doi.org/10.1182/blood.V126.23.2518.2518
Published: 2015